Skip to content
naulon
Not checkedNot checked for notices yet.

Active p21-Activated Kinase 1 Rescues MCF10A Breast Epithelial Cells from Undergoing Anoikis

Raymond E. Menard, Andrew P. Jovanovski, Raymond R. Mattingly

Neoplasia: An International Journal for Oncology Research · 2005

doi:10.1593/neo.04736 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

The protein kinase, PAKi, is overexpressed in human breast cancer and may contribute to malignancy through induction of proliferation and invasiveness. In this study, we examined the role of PAKi in the survival of detached MCF10A breast epithelial cells to test whether it may also regulate the early stages of neoplasia. MCF10A cells undergo anoikis, as measured by the cleavage of caspase 3 and poly(ADPribose) polymerase (PARP), after more than 8 hours of detachment. Endogenous Akt, PAKi, BAD are phosphorylated in attached MCF10A cells, but these phosphorylation events are all lost during the first 8 hours of detachment. Expression of constitutively active PAKi or Akt suppresses the cleavage of caspase 3 and PARP in detached MCF10A cells. Cooverexpression of active PAKi with dominant-negative Akt, or of active Akt with dominant-negative PAKi, still suppresses anoikis. Thus, Akt and PAKi enhance survival through pathways that are at least partially independent. PAKi-dependent regulation of anoikis is likely to occur early in the apoptotic cascade as expression of dominant-negative PAKi increased the cleavage of the upstream caspase 9, while constitutively active PAKi inhibited caspase 9 activation. These results support a role for activated PAKi in the suppression of anoikis in MCF10A epithelial cells.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.